Cellular Cardiac Electrophysiology

Coll-Vinent, B; Martin, A; Sanchez, J; Tamargo, J; Suero, C; Malagon, F; Varona, M; Cancio, M; Sanchez, S; Carbajosa, J; Rios, J; Casanovas, G; Rafols, C; del Arco, C; EMERG-AF Investigators.

Benefits of Emergency Departments' Contribution to Stroke Prophylaxis in Atrial Fibrillation The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation)

STROKE. 2017; 48(5): 1344 No. of citations: 32 [doi:10.1161/STROKEAHA.116.014855]

Ruilope, LM; Tamargo, J.

Aldosterone a Relevant Factor in the Beginning and Evolution of Arterial Hypertension

AMERICAN JOURNAL OF HYPERTENSION. 2017; 30(5): 468-469 No. of citations: 5 [doi:10.1093/ajh/hpx010]

Tamargo, J; Rosano, GMC; Delpon, E; Ruilope, L; Lopez-Sendon, J.

Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes

International Journal of Cardiology. 2017; 233: 1-11 No. of citations: 7 [doi:10.1016/j.ijcard.2016.11.124]

Ruilope, LM; Tamargo, J.

Renin-angiotensin system blockade: Finerenone

Nephrologie & Therapeutique. 2017; 13: 47-53 No. of citations: 16 [doi:10.1016/j.nephro.2017.02.003]

Caballero, R; Utrilla, RG; Amoros, I; Matamoros, M; Perez-Hernandez, M; Tinaquero, D; Alfayate, S; Nieto-Marin, P; Guerrero-Serna, G; Liu, QH; Ramos-Mondragon, R; Ponce-Balbuena, D; Herron, T; Campbell, KF; Filgueiras-Rama, D; Peinado, R; Lopez-Sendon, JL; Jalife, J; Delpon, E; Tamargo, J.

Tbx20 controls the expression of the KCNH2 gene and of hERG channels

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2017; 114(3): 416-425 No. of citations: 35 [doi:10.1073/pnas.1612383114]

Zamorano, JL; Lancellotti, P; Munoz, D; Aboyans, V; Asteggiano, R; Galderisi, M; Habib, G; Lenihan, DJ; Lip, GYH; Lyon, AR; Fernandez, TL; Mohty, D; Piepoli, MF; Tamargo, J; Torbicki, A; Suter, TM; Achenbach, S; Agewall, S; Badimon, L; Baron-Esquivias, G; Baumgartner, H; Bax, JJ; Bueno, H; Carerj, S; Dean, V; Erol, C; Fitzsimons, D; Gaemperli, O; Kirchhof, P; Kolh, P; Lancellotti, P; Nihoyannopoulos, P; Ponikowski, P; Roffi, M; Carneiro, AV; Windecker, S; Minotti, G; Cardinale, D; de Azambuja, E; Dent, S; Erol, C; Ewer, MS; Farmakis, D; Fietkau, R; Fitzsimons, D; McGale, P; Ringwald, J.

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)

EUROPEAN JOURNAL OF HEART FAILURE. 2017; 19(1): 9-42 No. of citations: 287 [doi:10.1002/ejhf.654]

Rivera-Torres, J; Calvo, CJ; Llach, A; Guzman-Martinez, G; Caballero, R; Gonzalez-Gomez, C; Jimenez-Borreguero, LJ; Guadix, JA; Osorio, FG; Lopez-Otin, C; Herraiz-Martinezd, A; Cabello, N; Vallmitjana, A; Benitez, R; Gordon, LB; Jalife, J; Perez-Pomares, JM; Tamargo, J; Delpon, E; Hove-Madsen, L; Filgueiras-Rama, D; Andres, V.

Cardiac electrical defects in progeroid mice and Hutchinson-Gilford progeria syndrome patients with nuclear lamina alterations

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2016; 113(46): 7250-7259 No. of citations: 56 [doi:10.1073/pnas.1603754113]

Kirchhof, P; Benussi, S; Kotecha, D; Ahlsson, A; Atar, D; Casadei, B; Castella, M; Diener, HC; Heidbuchel, H; Hendriks, J; Hindricks, G; Manolis, AS; Oldgren, J; Popescu, BA; Schotten, U; Van Putte, B; Vardas, P; Agewall, S; Camm, J; Esquivias, GB; Budts, W; Carerj, S; Casselman, F; Coca, A; De Caterina, R; Deftereos, S; Dobrev, D; Ferro, JM; Filippatos, G; Fitzsimons, D; Gorenek, B; Guenoun, M; Hohnloser, SH; Kolh, P; Lip, GYH; Manolis, A; McMurray, J; Ponikowski, P; Rosenhek, R; Ruschitzka, F; Savelieva, I; Sharma, S; Suwalski, P; Tamargo, JL; Taylor, CJ; Van Gelder, IC; Voors, AA; Windecker, S; Zamorano, JL; Zeppenfeld, K.

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

EUROPACE. 2016; 18(11): No. of citations: 3476 [doi:10.1093/europace/euw295]

Tamargo, J; Ruilope, LM.

Investigational calcium channel blockers for the treatment of hypertension

EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2016; 25(11): 1295-1309 No. of citations: 26 [doi:10.1080/13543784.2016.1241764]

Canon, S; Caballero, R; Herraiz-Martinez, A; Perez-Hernandez, M; Lopez, B; Atienza, F; Jalife, J; Hove-Madsen, L; Delpon, E; Bernad, A.

miR-208b upregulation interferes with calcium handling in HL-1 atrial myocytes: Implications in human chronic atrial fibrillation

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. 2016; 99: 162-173 No. of citations: 74 [doi:10.1016/j.yjmcc.2016.08.012]

Zamorano, JL; Lancellotti, P; Munoz, DR; Aboyans, V; Asteggiano, R; Galderisi, M; Habib, G; Lenihan, DJ; Lip, GYH; Lyon, AR; Lopez Fernandez, T; Mohty, D; Piepoli, MF; Tamargo, J; Torbicki, A; Suter, TM; Zamorano, JL; Aboyans, V; Achenbach, S; Agewall, S; Badimon, L; Baron-Esquivias, G; Baumgartner, H; Bax, JJ; Bueno, H; Carerj, S; Dean, V; Erol, C; Fitzsimons, D; Gaemperli, O; Kirchhof, P; Kolh, P; Lancellotti, P; Lip, GYH; Nihoyannopoulos, P; Piepoli, MF; Ponikowski, P; Roffi, M; Torbicki, A; Carneiro, AV; Windecker, S; Achenbach, S; Minotti, G; Agewall, S; Badimon, L; Bueno, H; Cardinale, D; Carerj, S; Curigliano, G; de Azambuja, E; Dent, S; Erol, C; Ewer, MS; Farmakis, D; Fietkau, R; Fitzsimons, D; Gaemperli, O; Kirchhof, P; Kohl, P; McGale, P; Ponikowski, P; Ringwald, J; Roffi, M; Schulz-Menger, J; Stebbing, J; Steiner, RK; Szmit, S; Carneiro, AV; Windecker, S.

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

EUROPEAN HEART JOURNAL. 2016; 37(36): 2768-2801 No. of citations: 1876 [doi:10.1093/eurheartj/ehw211]

Zannad, F; Stough, WG; Lipicky, RJ; Tamargo, J; Bakris, GL; Borer, JS; Garcia, MDA; Hadjadj, S; Koenig, W; Kupfer, S; McCullough, PA; Mosenzon, O; Pocock, S; Scheen, AJ; Sourij, H; Van der Schueren, B; Stahre, C; White, WB; Calvo, G.

Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion

European Heart Journal-Cardiovascular Pharmacotherapy. 2016; 2(3): 200-205 No. of citations: 35 [doi:10.1093/ehjcvp/pvw007]

Romero, M; Jimenez, R; Toral, M; Leon-Gomez, E; Gomez-Guzman, M; Sanchez, M; Zarzuelo, MJ; Rodriguez-Gomez, I; Rath, G; Tamargo, J; Perez-Vizcaino, F; Dessy, C; Duarte, J.

Vascular and Central Activation of Peroxisome Proliferator-Activated Receptor-beta Attenuates Angiotensin II-Induced Hypertension: Role of RGS-5

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2016; 358(1): 151-163 No. of citations: 17 [doi:10.1124/jpet.116.233106]

Toral, M; Romero, M; Jimenez, R; Robles-Vera, I; Tamargo, J; Martinez, MC; Perez-Vizcaino, F; Duarte, J.

Role of UCP2 in the protective effects of PPAR beta/delta activation on lipopolysaccharide-induced endothelial dysfunction

BIOCHEMICAL PHARMACOLOGY. 2016; 110: 25-36 No. of citations: 33 [doi:10.1016/j.bcp.2016.05.004]

Matamoros, M; Perez-Hernandez, M; Guerrero-Serna, G; Amoros, I; Barana, A; Nunez, M; Ponce-Balbuena, D; Sacristan, S; Gomez, R; Tamargo, J; Caballero, R; Jalife, J; Delpon, E.

Nav1.5 N-terminal domain binding to alpha 1-syntrophin increases membrane density of human Kir2.1, Kir2.2 and Nav1.5 channels

CARDIOVASCULAR RESEARCH. 2016; 110(2): 279-290 No. of citations: 75 [doi:10.1093/cvr/cvw009]

Delpon, MT; Demelo-Rodriguez, P; Ballesteros, JCC; de la Cruz, LV.

Psoas abscess caused by Staphylococcus lugdunensis

REVISTA ARGENTINA DE MICROBIOLOGIA. 2016; 48(2): 119-121 No. of citations: 3 [doi:10.1016/j.ram.2016.02.005]

Schmidt, M; Lamberts, M; Olsen, AMS; Fosboll, E; Niessner, A; Tamargo, J; Rosano, G; Agewall, S; Kaski, JC; Kjeldsen, K; Lewis, BS; Torp-Pedersen, C.

Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology

EUROPEAN HEART JOURNAL. 2016; 37(13): 1015-26 No. of citations: 122 [doi:10.1093/eurheartj/ehv505]

Ambrosio, G; Tamargo, J; Grant, PJ.

Non-haemodynamic anti-anginal agents in the management of patients with stable coronary artery disease and diabetes: A review of the evidence

Diabetes & Vascular Disease Research. 2016; 13(2): 98-112 No. of citations: 11 [doi:10.1177/1479164115609028]